Chewy (CHWY) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
9 Sep, 2026Executive summary
Net sales for Q2 reached $3.33 billion, up 7.3% year-over-year, at the high end of guidance, driven by growth in active customers and higher net sales per active customer.
Net income rose 29.8% year-over-year to $80.5 million, with net margin improving to 2.4%.
Adjusted EBITDA was $226.7 million (6.8% margin), up 23.7% year-over-year, exceeding guidance.
Active customers grew 3.8% year-over-year to 21.7 million, with net sales per active customer reaching $602.
Autoship customer sales increased 9.3% year-over-year, now representing 84.6% of net sales.
Financial highlights
Gross margin held steady at 30.4% year-over-year, with gross profit of $1.01 billion.
Adjusted net income was $148.8 million, up 5.5% year-over-year; diluted EPS increased to $0.20.
Free cash flow for the quarter was $89.5 million, with cash and cash equivalents at $611.0 million at quarter-end.
Operating income rose 32% to $92.0 million, with an operating margin of 2.8%.
Net margin improved by 40 basis points to 2.4% year-over-year.
Outlook and guidance
FY2026 net sales expected at $13.46–$13.57 billion (6.8–7.7% growth), with organic growth of 5.5–6.3%.
Adjusted EBITDA margin guidance raised to 6.7–6.8%, implying over 100 bps year-over-year expansion.
Q3 net sales expected at $3.323–$3.358 billion (6.6–7.7% growth), with adjusted EBITDA margin of 6.6–6.7%.
Management expects continued growth in active customers and net sales per active customer, supported by expanded healthcare and specialty offerings.
No meaningful consumer recovery assumed in guidance; outlook based on stable trends and continued share gains.
Latest events from Chewy
- Health services, AI, and disciplined investment drive growth and margin expansion.CHWY
Goldman Sachs Global Consumer and Retail Conference - All proposals passed, with annual executive compensation votes approved and proper governance observed.CHWY
AGM 2026 - Net sales rose 7.7% to $3.36B, with record profitability and $200M in share repurchases.CHWY
Q1 2027 - Proxy covers board elections, auditor ratification, executive pay, and ESG priorities.CHWY
Proxy filing - Virtual annual meeting to vote on directors, auditor, and executive pay, July 9, 2026.CHWY
Proxy filing - Pet e-commerce growth, AI-driven efficiencies, and vet clinic expansion drive future gains.CHWY
J.P. Morgan 54th Annual Global Technology, Media and Communications Conference - Integrated clinics and Modern Animal acquisition drive revenue and leadership in pet health.CHWY
Corporate presentation - Net sales and profitability grew in 2025, with strong 2026 growth and margin guidance.CHWY
Q4 2026 - Profitability and customer growth outpace targets, with AI and vet clinics fueling future gains.CHWY
Morgan Stanley Technology, Media & Telecom Conference 2026